Attention Deficit/hyperactivity Disorder (ADHD) by Venter, A
People who suffer from ADHD are far more likely than normal to drop out of
school (32 - 40%), to have few or no friends (50 - 70%), to underperform at
work (70 - 80%), to engage in antisocial activities (40 - 50%), and to use tobac-
co and illegal drugs.  Children growing up with ADHD are more likely to experi-
ence teen pregnancy (40%), to speed excessively and have multiple car acci-
dents, and to experience depression (20 - 30%) and personality disorders 
(18 - 25%) as adults.  This condition needs to be taken seriously, and those who
manage it should keep abreast of the relevant science and progress regarding its
management.
AETIOLOGY
About 8% of any population could have an ADHD (range 5 - 10%), with boys
reported to be more affected than girls (3:1). However, in a group described as
having attention deficit disorder without hyperactivity, girls outnumber boys.
Genetic factors probably play a role in this disorder in more than 80% of cases.  
The pathophysiology in children with ADHD has been localised to 3 areas in the
brain —  the frontal lobe, its connection to the basal ganglia, and the relation-
ship to the central aspects of the cerebellum.  In ADHD these areas show less
activity and may also be relatively smaller. The defect appears to be in the avail-
ability of dopamine in these areas. 
The home environment, parental management abilities, stressful life events or
deviant relationships are important, but do not cause ADHD, nor does sensitivity
to sugar, colourants and preservatives. ADHD is also not a direct result of aller-
gies, intolerance or deficiencies in the diet, although these factors may adversely
affect some patients.
DIAGNOSIS
In some children signs and symptoms suggestive of ADHD may be normal vari-
ants or result from a medical condition or an affective disorder.  These may be
secondary to learning disabilities, partial sensory deficits or even low cognitive
potential.  The diagnosis therefore depends on an adequate history and subse-
quent collaboration from various sources.  The more thorough the history and the
more members of the team who are brought in to provide collaborative data, the
more likely it is that the diagnosis will be correct.
Attention deficit
The diagnosis is based on the Diagnostic and Statistical Manual of Mental
Disorders, 4th ed. (DSM IV) criteria, which divide the symptoms of ADHD into 2
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groups.  The first have to do with inat-
tention.  If a child exhibits 6 or more
of the criteria below that have persist-
ed for more than 6 months, the diag-
nosis is probable:
• fails to give close attention to detail
and makes careless mistakes (Fig. 1)
• often has difficulty sustaining atten-
tion in tasks or play activities 
• often does not seem to listen when
spoken to directly
• does not follow through instructions
and fails to finish schoolwork 
• often has difficulty organising tasks
and activities 
• often avoids, dislikes or is reluctant
to engage in tasks requiring mental
effort 
• often loses things needed for tasks
or activities 
• is often distracted by extraneous
stimuli 
• is often forgetful in daily activities.
The investment, organisation and
maintenance of attention and effort
are impaired in children with ADHD.
Teachers and parents describe these
children as seemingly unable to listen
or follow instructions in class, finish
work independently, sequence audito-
ry and visual stimuli, attend to detail
or work alone.  Affected children are
more inclined to be distracted than
their peers, to daydream, to have
poor organisational skills and to perse-
verate in tasks  (Fig. 2). However,
ADHD does not imply that the child
cannot pay attention at all. Where the
situation is sufficiently novel, or they
have a particular interest, attention
can be held. It is therefore not uncom-
mon to have a history of being able to
watch television for hours on end!
They commonly have good days and
bad days (Fig. 3), which can lead to
frustration for teachers, parents and the
child, as there is always the feeling that
the child could have done better.
Hyperactivity
The second part of the DSM IV relates
to hyperactivity and impulsivity. For
hyperactivity and impulsivity 6 of the
following 9 criteria need to be met by
the child, again for more than 6
months. There are 6 criteria for hyper-
activity:
• often fidgets with his/her hands/
feet or squirms 
• often leaves his/her seat in the
classroom 
• often runs about or climbs exces-
sively 
• often has difficulty playing or
engaging in leisure activities quietly 
• often on the go, apparently driven
by a motor 
• often talks excessively.
Not all children act as if they are
‘driven’.  Most present as fidgety, and
talkativeness is often an indication of
hyperactivity, particularly if the child is
long-winded, seldom gets to the point
and moves from topic to topic.  
Impulsivity
There are 3 criteria for impulsivity:
• the child often blurts out answers
before questions have been com-
pleted 
• the child has difficulty waiting
his/her turn 
• the child often interrupts or intrudes
on others.
These children often react before they
have understood a problem clearly.
They regularly start an activity before
they have understood the instruction
and inevitably get it wrong, and may
make many careless mistakes in class,
leading to poor marks in exams.
Impulsivity is also reflected by a low
frustration tolerance, antisocial behav-
iour (destroyers and liars), poor plan-
ning and judgement, failure to finish
tasks, sloppy work, approximations in
reading and writing, reckless behav-
iour and being accident prone,
impaired sphincter control and an
inability to delay gratification.
The DSM IV criteria state that the
hyperactive, impulsive and inattentive
symptoms should have caused impair-
ment before the age of 7 and be pres-
ent in more than 1 setting.  An EEG
plays no part in the diagnosis or prog-
nosis of ADHD.
ADHD types
Based on the DSM IV criteria there are
4 types of ADHD:
Combined type. These children ful-
fil the majority of criteria of the DSM
IV. They often present in the pre-school
year but may present as late as grade
2 or 3.  They have inattention, impul-
sivity as well as hyperactivity.
Predominantly inattentive type.
Girls predominate in this group.  They
Fig. 1. Draw-a-Person of a 7-year-old
boy with ADHD. Notice the lack of
attention to detail.
Fig. 2. Poor-quality work — typical in
ADHD.
Fig. 3. Perseveration in a Draw-a
Person. Bad hair day!
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are low-toned and floppy, but not exces-
sively impulsive or hyperactive and so
are not noticed in the classroom. Their
inattentiveness causes them to be
unaware of their surroundings, and they
respond very well to stimulant therapy.
Predominantly hyperactive
impulsive type. These are usually
boys who often present very young 
(3 - 4 years) with unacceptable behav-
iour.
In partial remission. This is usually
ADHD diagnosed in older children who
do not present with all the symptoms.
CO-MORBIDITIES (ASSOCIATED
MENTAL DISORDERS)
• Oppositional defiant disorder.
• Conduct disorders.
• Communication disorders.
• Gilles de la Tourette’s syndrome.
• Learning disorders.
POOR SELF-ESTEEM
Self-esteem is a problem in most of
these children, which they may try to
conceal with bravado or clowning in
class.  Praise for effort will help, even
if the end-product is mediocre.
Another strategy is to encourage the
child to participate in activities outside
the school that will make them unique,
for example equestrian sport.
ABERRANT SOCIAL
BEHAVIOUR
Most of these children are unrespon-
sive to social demands and most disci-
plinary efforts fail. Their initially
charming and talkative type of interac-
tion becomes tiresome once it is clear
that they are domineering and require
instant gratification. 
MANAGEMENT
The management of ADHD is multidis-
ciplinary, as a single intervention is




• psychosocial (behaviour modifica-
tion) 
• diet manipulation and supplements.
In this article the medical management
is discussed, but this does not imply
that other interventions are less impor-
tant.
Medical management
The doctor often is exclusively respon-
sible for pharmacological manage-
ment.  It is important first to exclude
other medical causes for these symp-
toms such as sleep apnoea, obstructive
airway disease, use of other medica-
tions and poorly managed allergies.
The history and examination includes
the child’s developmental level. Check
vision and hearing.  Once the diagno-
sis is made, refer the parents and chil-
dren to social support groups and also
give some tips on behaviour manage-
ment if necessary.
Stimulants 
Stimulants are the mainstay of the
medical management of children with
ADHD.  These have been used for
over 40 years and found to be benefi-
cial in about 70% of children. In fact,
recent studies have found stimulants to
be superior to a combination of stimu-
lants and behaviour modification,
although this does not imply that other
treatment modalities should not be
used as well. 
Short-acting methylphenidate (Ritalin)
is effective for about 4 hours, and has
to be given twice a day.  Ritalin SR, a
longer-acting methylphenidate, is also
available, but is not as effective as 2
short-acting tablets daily because of its
distinct activity plateau.  It is also only
available in 20 mg tablets, making
dose manipulation difficult. However,
Ritalin LA is available in 20, 30 and
40 mg tablets and mimics the effectivi-
ty profile of short-acting
methylphenidate given twice a day.
Clinical prescription
Once treatment has been decided on,
a 2-week trial of short-acting
methylphenidate is the initial therapy.
In preschool children and small grade
1 children, 5 mg should be adequate.
Most other children will need 1 tablet
in the morning. This is prescribed for
2 weeks, generally without the
teacher’s knowledge for the first week,
although I do encourage parents to
discuss it with the teachers, at least
before the second week.
The reasons for the 2-week trial are
the following:
• To ascertain whether the medication
has a beneficial effect, usually evi-
dent within 1 or 2 days.
• To monitor side-effects, which must
be explained to parents.  The most
important are anorexia and dys-
phoria, which often settles after the
first 3 days, and the rebound
effect, where children appear to be
worse in the afternoons but are
well controlled in the mornings.  If
parents are not warned about these
side-effects, they will stop the med-
ication within the first 3 days.
The home environment,
parental management abili-
ties, stressful life events or
deviant relationships are
important, but do not cause
ADHD, nor does sensitivity
to sugar, colourants and
preservatives.
The pathophysiology in
children with ADHD has
been localised to 3 areas
in the brain —  the frontal
lobe, its connection to the
basal ganglia, and the
relationship to the central
aspects of the cerebellum.
People who suffer from
ADHD are far more likely
than normal to drop out of
school (32 - 40%), to have
few or no friends (50 -
70%), to underperform at
work (70 - 80%), to
engage in antisocial activi-
ties (40 - 50%), and to use
tobacco and illegal drugs.
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The effect of the medication is usually
visible within 15 - 30 minutes and
lasts for 2 - 4 hours.  Stimulants should
not be started at the same time as
starting a new year at school or an
altered classroom setting.  If the bene-
ficial effect of the medication is obvi-
ous, therapy should be continued and
monitored with rating scales (such as
a Conners questionnaire).  Dosage
and time of administration need to be
tailored to the child’s specific needs.
He/she may not be aware of the ben-
efits.  If the effect is not noticeable or
is uncertain an increased dose can be
tried, and if this does not have any
effect the trial should be abandoned
and specialist help sought.  
The tablet should be taken just before
leaving for school in the morning and
not chewed, but swallowed whole.
The Ritalin LA capsule can be opened
and its contents given with a puree
(not liquids). To be of use during
homework, stimulants could be pre-
scribed 3 times a day. It is also recom-
mended, depending on side-effects,
that children do not have weekend or
vacation breaks, but use the medica-
tion continuously (Figs 4 and 5).
Termination of medication should be
based on a clinical trial off stimulants
during which behaviour is monitored
closely.  Frequently there are brief, acci-
dental trials off medication when a dose
is forgotten.  If ADHD behaviours return
immediately, the child is not yet ready
for a planned trial off medication.  If
not, a planned trial off medication for 2
weeks is arranged, usually during less
stressful periods.  Thereafter the medica-
tion can be stopped if there is no deteri-
oration of ADHD symptomatology.  The
child should still be monitored for at
least a year.
Contraindications to the use of
methylphenidate
There are probably no absolute con-
traindications to the use of
methylphenidate, but relative contraindi-
cations include:





• Gilles de la Tourette’s syndrome.
Side-effects of methylphenidate.
Methylphenidate is very safe.
Worldwide clinical experience over
more than 40 years has shown few
reports of adverse effects or serious toxi-
city, even when there has been inten-
tional overdose.  In children most side-
effects disappear as tolerance develops
to the medication or resolve when the
dose is decreased.  Yet resistance to its
use in the management of ADHD per-
sists mainly because of reputed side-
effects.  In a double- blind,
methylphenidate-placebo trial the fre-
quency of side-effects was similar for
both the stimulant and the placebo.
Many of the side-effects reported were
similar to the symptoms of ADHD them-
selves.
The most common side-effects are:
• anorexia and weight loss — general-
ly mild and affecting less than half of
treated children
• insomnia and nervousness — most
children return to their original sleep-
ing pattern after 2 - 3 months
• vague stomach aches/dry
mouth/nausea — settles after 2 - 3
weeks
• dysphoria — settles in about 3
days
• transient dyskinetic states, tremors
and tics
• cardiac symptoms — usually mild
palpitations but can be more severe
in intravenous drug abusers
• long-term effects on weight and
height — do not appear to be clini-
cally significant and slight reduc-
tions in weight and height do not
persist into adulthood
• skin rashes and fixed drug reac-
tions are very rare.
Drug abuse. Methylphenidate is a
very mild stimulant and has a low
potential for abuse.  Eight outcome
studies concluded that stimulant thera-
py does not promote drug abuse in
adolescents.  In fact, recent reports
seem to indicate that stimulants may
protect children against later drug
abuse.  It should be appreciated that
individuals with ADHD have a far
higher risk for substance abuse than
the normal population.  The use of
stimulants decreased this risk to levels
similar to those in the general popula-
tion.
Antidepressants
Several antidepressants are used for
the treatment of ADHD, the tricyclics
being the most common and specifical-
ly indicated with concurrent depres-
sion and anxiety, in a once daily
dose.  If higher daily doses (over 50
mg) are prescribed, a pre-treatment
ECG is usually required.  Side-effects
include dry mouth and decreased
appetite.
Fig. 4. Example of poor sequencing
skills.
Fig. 5. Improvement on stimulant med-
ication (same child as Fig. 4).
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Clonidine
Clonidine is effective in about 70% of
ADHD children.  It is used for hyper-
aroused, aggressive states and it can
be used in Tourette’s disorder and in
children with tics.  It is often most
effectively used in sleep disorders.  It
has many side-effects, including som-
nolence, sedation, irritability and
hypotension.  
Risperidone
Risperidone is not registered for the
treatment of ADHD.  It is useful for
aggressive, violent behaviour and
sleep disorders.  It is therefore of great
benefit in children with behaviour dis-
orders, such as in Tourette’s disorder,
developmental delay, autism, perva-
sive developmental delay and mental
retardation.
Atomoxitine
Atomoxitine has been found to be
effective in the treatment of ADHD in
children and adolescents.  It appears 
to be safe and well tolerated, nausea
being its main side-effect.  It should be
available in South Africa by 2005.
ADHD is not a benign disorder and
its management is important, espe-
cially as it may lead to so much dys-
function in adults.
Eighty per cent of cases are polyge-
netically inherited, and in these cases
there is dopamine deficiency in the
synapses of specific areas of the
brain due to overactive elimination.
The diagnosis is based on the DSM
IV criteria, and 4 distinct clinical vari-
ants are identifiable.
Co-morbidity is common, especially
learning disorders.
The management of ADHD demands
a multi-modal approach, and may
include medical, educational, psy-
chosocial and dietary interventions.
Stimulants are the mainstay of the
medical management of ADHD; they
are effective and safe, with relatively
few long- and short-term side-effects.
A 2-week clinical trial with a short-
acting methylphenidate is important
to ascertain whether the medication is
beneficial and to monitor side-effects.
The most important contraindication
to the use of methylphenidate is
uncontrolled epilepsy.
If taken as prescribed the side-effects
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